Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Rating of “Hold” by Analysts

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has earned an average rating of “Hold” from the twelve analysts that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and five have assigned a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $21.4545.

Several equities analysts recently issued reports on the stock. Scotiabank reduced their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Cantor Fitzgerald lifted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Truist Financial raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a research note on Wednesday. Finally, Barclays assumed coverage on Sabra Healthcare REIT in a report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price objective on the stock.

Institutional Trading of Sabra Healthcare REIT

Several hedge funds and other institutional investors have recently added to or reduced their stakes in SBRA. Rothschild Investment LLC increased its stake in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares during the last quarter. Versant Capital Management Inc boosted its position in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after acquiring an additional 603 shares during the last quarter. Strengthening Families & Communities LLC purchased a new stake in Sabra Healthcare REIT in the fourth quarter valued at approximately $29,000. Finally, Danske Bank A S purchased a new stake in Sabra Healthcare REIT in the third quarter valued at approximately $30,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Price Performance

SBRA stock traded down $0.26 during trading on Friday, hitting $19.62. The stock had a trading volume of 2,267,446 shares, compared to its average volume of 3,287,241. The company’s 50 day moving average price is $19.67 and its two-hundred day moving average price is $19.70. Sabra Healthcare REIT has a 1-year low of $17.17 and a 1-year high of $21.28. The stock has a market cap of $4.95 billion, a price-to-earnings ratio of 31.14, a price-to-earnings-growth ratio of 1.46 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. During the same period in the prior year, the firm earned $0.37 EPS. The firm’s quarterly revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, sell-side analysts forecast that Sabra Healthcare REIT will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio is 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.